Sempokuya T, Zhang G, Nakagawa K. Temporal trends of cirrhosis associated conditions. World J Hepatol 2019; 11(1): 74-85 [PMID: 30705720 DOI: 10.4254/wjh.v11.i1.74]
Corresponding Author of This Article
Tomoki Sempokuya, MD, Doctor, Department of Internal Medicine, the Queen’s Medical Center, 1356 Lusitana Street, 7th Floor, 702, Honolulu, HI 96813, United States. tsempoku@hawaii.edu
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Basic Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Tomoki Sempokuya, Guangxiang Zhang, Kazuma Nakagawa, Department of Internal Medicine, the Queen’s Medical Center, Honolulu, HI 968132, United States
Author contributions: Sempokuya T conception and designed the study, acquired data, drafted and edited this manuscript, Zhang G performed statistical analysis and interpretation of data, drafted and edited the manuscript and Nakagawa K supervised the study and edited the manuscript.
Institutional review board statement: This study utilized publicly-accessible, de-identified administrative level; aggregate data, rather than patient-specific data, approval from the institutional review board was not required to conduct the study.
Institutional animal care and use committee statement: No animal subjects were utilized in this study, so involvement was not needed.
Conflict-of-interest statement: All authors disclose no conflict of interest.
Data sharing statement: No additional data are available.
ARRIVE guidelines statement: The authors have carefully reviewed the ARRIVE guidelines, and the manuscript was prepared and edited in accordance to the ARRIVE guidelines.
Corresponding author: Tomoki Sempokuya, MD, Doctor, Department of Internal Medicine, the Queen’s Medical Center, 1356 Lusitana Street, 7th Floor, 702, Honolulu, HI 96813, United States. tsempoku@hawaii.edu
Telephone: +1-808-5862910 Fax: +1-808-5867486
Received: October 12, 2018 Peer-review started: October 15, 2018 First decision: November 1, 2018 Revised: December 29, 2015 Accepted: January 9, 2019 Article in press: January 9, 2019 Published online: January 27, 2019 Processing time: 107 Days and 21.9 Hours
Core Tip
Core tip: Understanding recent temporal trends of cirrhosis-associated conditions is an important aspect of developing strategies to reduce health care cost. Our study showed increasing trends of hospital discharges related to cirrhosis-associated conditions despite the decreasing trends for total hospital discharges across the nation. Importantly, hepatic coma associated with viral hepatitis showed rapid increase in discharge volume in comparison to hepatic coma not associated with viral hepatitis. After adjusting for inflation, cirrhosis associated conditions showed disproportionately greater increase in aggregate cost compare to national trends. This suggests that prevention of hospitalizations secondary to cirrhosis-associated conditions likely reduces overall health care cost.
